March 14, 2011
STELLAPHARM was born to care and protect patient’s health, to help enhancing their lives and living longer. Your health, for today and for future.
On March 12, 2011, STADA-VN organized the seminar, “Update on the progress for the treatment of Hypertension and Coronary Artery Disease” lectured by Assoc. Prof. Pham Nguyen Vinh – Vice Chairman of Vietnam Cardiovascular Association, Director of Tam Duc Heart Hospital. About 200 doctors from the southern provinces and cities attended the seminar. In the seminar, new information on the diagnostic and treatment of heart disease were exchanged.
STELLAPHARM is one of leading generics pharmaceutical companies and strong producer of anti-viral drugs in Vietnam. The company established in Vietnam in 2000; and focuses on both prescription drugs and non-prescription especially in cardiovascular diseases, anti-viral drugs, anti-diabetics drugs, etc. and our products are now used by millions of patients in more than 50 countries worldwide.
The company is globally recognized for its quality through our facilities have been audited and approved by stringent authority like EMA, PMDA, Taiwan GMP, local WHO and others.
Additional information for this article: Stellapharm J.V. Co., Ltd. – Branch 1
A: 40 Tu Do Avenue, Vietnam – Singapore Industrial Park, An Phu Ward, Thuan An Town, Binh Duong Province, Vietnam
T: +84 274 376 7470 | F: +84 274 376 7469 | E: email@example.com | W: www.stellapharm.com
On 06 May 2011, STADA-VN has participated in the Conference and Exhibition on Drug held by Ho Chi Minh City Health Department together with more than 40 pharmaceutical manufacturers.
In the second quarter of 2010, STADA-VN held a series of Cardiovascular Seminars for hospital doctors working outside Ho Chi Minh City.